Items by Godage, Himali

2013

Godage, H. Y., Riley, A. M., Woodman, T. J., Thomas, M. P., Mahon, M. F. and Potter, B. V. L., 2013. Regioselective opening of myo-inositol orthoesters: mechanism and synthetic utility. Journal of Organic Chemistry, 78 (6), pp. 2275-2288.

2012

Turner, B. L., Cheesman, A. W., Godage, H. Y., Riley, A. M. and Potter, B. V. L., 2012. Determination of neo-and D-chiro-inositol hexakisphosphate in soils by solution 31P NMR spectroscopy. Environmental Science & Technology, 46 (9), pp. 4994-5002.

2011

Falasca , Marco, 2011. Novel Inositol Phosphate Derivatives. A61K31/661-WO2011064559 (A2), 03 June 2011.

2010

Falasca, M., Chiozzotto, D., Godage, H. Y., Mazzoletti, M., Riley, A. M., Previdi, S., Potter, B. V. L., Broggini, M. and Maffucci, T., 2010. A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. British Journal of Cancer, 102 (1), pp. 104-114.

2009

Veiga, N., Torres, J., Godage, H. Y., Riley, A. M., Dominguez, S., Potter, B. V. L., Diaz, A. and Kremer, C., 2009. The behaviour of inositol 1,3,4,5,6-pentakisphosphate in the presence of the major biological metal cations. Journal of Biological Inorganic Chemistry, 14 (7), pp. 1001-1013.

2006

Riley, A. M., Godage, H. Y., Mahon, M. F. and Potter, B. V. L., 2006. Chiral desymmetrisation of myo -inositol 1,3,5-orthobenzoate gives rapid access to precursors for second messenger analogues. Tetrahedron: Asymmetry, 17, pp. 171-174.

Godage, H. Y., Riley, A. M., Woodman, T. J. and Potter, B. V. L., 2006. Regioselective hydrolysis of myo-inositol 1,3,5-orthobenzoate via a 1,2-bridged 2'-phenyl-1,3'-dioxolan-2'-ylium ion provides a rapid route to the anticancer agent Ins(1,3,4,5,6,)P5. Chemical Communications, 2006 (28), pp. 2989-2991.

2005

Maffucci, T., Piccolo, E., Cumashi, A., Lezzi, M., Riley, A. M., Saiardi, A., Godage, H. Y., Rossi, C., Broggini, M., Iacobelli, S., Potter, B. V. L., Innocenti, P. and Falasca, M., 2005. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Research, 65 (18), pp. 8339-8349.